Maze Therapeutics Inc. (MAZE) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Maze Therapeutics Inc.

    NASDAQ: MAZE · Real-Time Price · USD
    27.11
    0.61 (2.30%)
    At close: Oct 03, 2025, 3:59 PM
    27.11
    0.00%
    After-hours: Oct 03, 2025, 07:14 PM EDT

    Maze Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
    Net Income
    		 52.23M -100.42M -114.94M
    Depreciation & Amortization
    		 3.3M 4.09M 3.82M
    Stock-Based Compensation
    		 9.65M 8.75M 6.74M
    Other Working Capital
    		 -1.32M -6.71M 541K
    Other Non-Cash Items
    		 12.3M 7.07M 8.42M
    Deferred Income Tax
    		 n/a n/a n/a
    Change in Working Capital
    		 -1.52M -6.32M -3.24M
    Operating Cash Flow
    		 75.95M -86.83M -99.2M
    Capital Expenditures
    		 -1.15M -441K -1.97M
    Cash Acquisitions
    		 n/a n/a -1.2M
    Purchase of Investments
    		 n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a
    Investing Cash Flow
    		 -1.15M -441K -3.17M
    Debt Repayment
    		 24.48M 16.18M n/a
    Common Stock Repurchased
    		 n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a
    Other Financial Acitivies
    		 -2.42M n/a 154K
    Financial Cash Flow
    		 92.85M 16.39M 1.73M
    Net Cash Flow
    		 167.65M -70.88M -100.64M
    Free Cash Flow
    		 74.81M -87.27M -101.17M

    Add to Watchlist